The Role of Naltrexone in the Management of Drug Abuse

Overview

Journal Med Toxicol

Specialty Toxicology

Date 1987 Mar 1

PMID 3553834

Citations 1

Authors

H M Ginzburg

M G MACDONALD

Affiliations

Soon will be listed here.

Citing Articles

Naltrexone. A review of its pharmacodynamic and pharmacokinetic properties and therapeutic efficacy in the management of opioid dependence.

Gonzalez J, Brogden R Drugs. 1988; 35(3):192-213.

PMID: 2836152 DOI: 10.2165/00003495-198835030-00002.

References

Ginzburg H . Intravenous drug users and the acquired immune deficiency syndrome. Public Health Rep. 1984; 99(2):206-12. PMC: 1424536. View

. Narcotic antagonists: naltrexone pharmacochemistry and sustained-release preparations. NIDA Res Monogr. 1981; 28:1-273. View

Martin W, Jasinski D, Mansky P . Naltrexone, an antagonist for the treatment of heroin dependence. Effects in man. Arch Gen Psychiatry. 1973; 28(6):784-91. DOI: 10.1001/archpsyc.1973.01750360022003. View

KLEBER H . Naltrexone. J Subst Abuse Treat. 1985; 2(2):117-22. DOI: 10.1016/0740-5472(85)90036-4. View

Martin W, Gorodetzky C . Demonstration of tolerance to and physical dependence of N-allylnormorphine (nalorphine). J Pharmacol Exp Ther. 1965; 150(3):437-42. View

Judson B, Carney T, Goldstein A . Naltrexone treatment of heroin addiction: efficacy and safety in a double-blind dosage comparison. Drug Alcohol Depend. 1981; 7(4):325-46. DOI: 10.1016/0376-8716(81)90049-1. View

ROSENKRANTZ H . Physiologic and morphologic changes and incidence of neoplasms in mice and rats fed naltrexone HCl for 24 months. J Clin Psychiatry. 1984; 45(9 Pt 2):11-4. View

Herman B, Holtzman S . Repeated administration of naltrexone and diprenorphine decreases food intake and body weight in squirrel monkeys. Life Sci. 1984; 34(1):1-12. DOI: 10.1016/0024-3205(84)90324-2. View

Atkinson R, Berke L, DRAKE C, Bibbs M, Williams F, Kaiser D . Effects of long-term therapy with naltrexone on body weight in obesity. Clin Pharmacol Ther. 1985; 38(4):419-22. DOI: 10.1038/clpt.1985.197. View

10.

Washton A, Pottash A, Gold M . Naltrexone in addicted business executives and physicians. J Clin Psychiatry. 1984; 45(9 Pt 2):39-41. View

11.

. Clinical evaluation of naltrexone treatment of opiate-dependent individuals. Report of the National Research Council Committee on Clinical Evaluation of Narcotic Antagonists. Arch Gen Psychiatry. 1978; 35(3):335-40. View

12.

FREEDMAN A, Fink M, Sharoff R, Zaks A . Clinical studies of cyclazocine in the treatment of narcotic addiction. Am J Psychiatry. 1968; 124(11):1499-504. DOI: 10.1176/ajp.124.11.1499. View

13.

Verebey K, Volavka J, MULE S, Resnick R . Naltrexone: disposition, metabolism, and effects after acute and chronic dosing. Clin Pharmacol Ther. 1976; 20(3):315-28. DOI: 10.1002/cpt1976203315. View

14.

Senay E, Dorus W, Goldberg F, Thornton W . Withdrawal from methadone maintenance. Rate of withdrawal and expectation. Arch Gen Psychiatry. 1977; 34(3):361-7. DOI: 10.1001/archpsyc.1977.01770150119014. View

15.

Maggio C, Presta E, Bracco E, Vasselli J, Kissileff H, Pfohl D . Naltrexone and human eating behavior: a dose-ranging inpatient trial in moderately obese men. Brain Res Bull. 1985; 14(6):657-61. DOI: 10.1016/0361-9230(85)90115-7. View

16.

Zaks A, Jones T, Fink M, FREEDMAN A . Naloxone treatment of opiate dependence. A progress report. JAMA. 1971; 215(13):2108-10. View

17.

Verebey K . The clinical pharmacology of naltrexone: pharmacology and pharmacodynamics. NIDA Res Monogr. 1981; 28:147-58. View

18.

Brahen L, Wiechert V, Capone T . Narcotic antagonist treatment of the criminal justice patient-institutional vs outpatient-including a 24 hour detox naltrexone induction regimen with oral medication. NIDA Res Monogr. 1976; (9):93-8. DOI: 10.1037/e497452006-018. View

19.

Volavka J, Resnick R . Letter: Treatment of accidental naltrexone-induced withdrawal. Am J Psychiatry. 1976; 133(2):233. DOI: 10.1176/ajp.133.2.233a. View

20.

Gritz E, Shiffman S, Jarvik M, Schlesinger J, Charuvastra V . Naltrexone: physiological and psychological effects of single doses. Clin Pharmacol Ther. 1976; 19(6):773-6. DOI: 10.1002/cpt1976196773. View